Disruption of these degradation pathways through mutations at either the phosphorylation or sumoylation sites leads to persistent cyclin D1 stabilization, promoting B lymphocyte transformation and a lymphoma-like phenotype reminiscent of mantle cell lymphoma (MCL) (Lu et al. 2024). The gene discussed is CCND1; the disease is lymphoma.